Patent US4607950A successfully refreshed from Google Patents.
US5047321A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for analysis of cellular components of a fluid
Assignee: Becton Dickinson and Co
•
Filing: 1988-06-15
•
Granted: 1991-09-10
•
Expires: 2008-06-15
Abstract
Abstract A method for multi-parameter analysis of cells in a body fluid sample is described which makes use of a plurality of fluorescence measurements, comprising at least two nucleic acid dyes and at least one fluorescently labelled cell surface marker, and a plurality of light scattering measurements. A kit containing the nucleic acid dyes and cell surface marker also is described.
Inventors
- 👤 Michael R. Loken
- 👤 Leon W. M. M. Terstappen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 17:12
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/569; G01N33/56966; G01N33/56972; G01N15/00; G01N15/10; G01N15/14; G01N15/1456; G01N15/1459; G01N33/56977; G01N33/575; G01N33/5758; G01N33/5759; G01N2015/1006; G01N2015/1402; G01N2333/00; G01N2333/435; G01N2333/705; Y; Y10; Y10S; Y10S435/00; Y10S435/973; Y10S436/00; Y10S436/80; Y10S436/805; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
144 words
A method for multi-parameter analysis of cells in a body fluid wherein said method comprises the steps of: 1) taking a fluid sample from an individual; 2) adding two fluorescent nucleic acid dyes to said sample wherein one dye will differentially label DNA and wherein the other dye will differentially label RNA, and further wherein each dye has a fluorescent peak emission spectra different from the other; 3) adding a fluorescently labelled cell surface marker to said sample, wherein said marker recognizes an antigen that is differentially expressed on said cells in said fluid sample and wherein said fluorescent label has a peak emission spectra different from said fluorescent dyes; and 4) analyzing said cells in said sample in an instrument capable of detecting and recording three channels of fluorescence and two channels of light scattering for each of the cells in said sample.
Claim 2
Independent Claim
144 words
A method for multi-parameter analysis of cells in a body fluid wherein said method comprises the steps of: 1) taking a fluid sample from an individual; 2) adding two fluorescent nucleic acid dyes to said sample wherein one dye will differentially label DNA and wherein the other dye will differentially label RNA, and further wherein each dye has a fluorescent peak emission spectra different from the other; 3) adding a fluorescently labelled cell surface marker to said sample, wherein said marker recognizes an antigen that is differentially expressed on said cells in said fluid sample and wherein said fluorescent label has a peak emission spectra different from said fluorescent dyes; and 4) analyzing said cells in said sample in an instrument capable of detecting and recording three channels of fluorescence and two channels of light scattering for each of the cells in said sample.
Claim 3
Dependent Claim
30 words
The method of claim 1 wherein the body fluid comprises peritoneal, spinal or brain fluid, urine, whole blood or a cell suspension of bone marrow, lymph node, liver or spleen.
Claim 4
Dependent Claim
12 words
The method of claim 2 wherein the body fluid is whole blood.
Claim 5
Dependent Claim
12 words
The method of claim 2 wherein the body fluid is bone marrow.
Claim 6
Dependent Claim
14 words
The method of claim 1 wherein one of the nucleic acid dyes is LDS-751.
Claim 7
Dependent Claim
14 words
The method of claim 1 wherein one of the nucleic acid dyes is Thiazole-Orange.
Claim 8
Dependent Claim
15 words
The method of claim 1 wherein the two nucleic acids dyes are LDS-751 and Thiazole-Orange.
Claim 9
Dependent Claim
18 words
The method of claim 1 wherein the cell surface marker is a monoclonal antibody conjugated to a fluorochrome.
Claim 10
Dependent Claim
14 words
The method of claim 8 wherein the monoclonal antibody is a CD45 monoclonal antibody.
Claim 11
Dependent Claim
12 words
The method of claim 9 wherein the CD45 monoclonal antibody is HLe-1.
Claim 12
Dependent Claim
10 words
The method of claim 8 wherein the fluorochrome is phycoerythrin.
Claim 13
Dependent Claim
18 words
The method of claim 8 wherein the monoclonal antibody conjugated to a fluorochrome is HLe-1 conjugated to phycoerythrin.
Claim 14
Dependent Claim
31 words
The method of claim 1 wherein the sample taken in step 1) is split into one or more components and one of said components is diluted less than the other components.
Claim 15
Dependent Claim
123 words
A method for correcting a multi-parameter analysis of a bone marrow sample to adjust for increased white blood cell levels due to blood contamination of the bone marrow sample which comprises the steps of: 1) performing the steps of the method of claim 1 on whole blood; 2) determining the percentages of various white blood cell components in the blood; 3) performing the steps of the method of claim 1 on bone marrow; 4) determining the absolute counts of various white blood cell components in the bone marrow; and 5) multiplying each of the percentage obtained in step (2) by the total number of cells in the bone marrow sample and subtracting that number from the respective absolute counts obtained in step 4).
Claim 16
Independent Claim
89 words
A method for five-parameter analysis of cells in a blood sample wherein said method comprises the steps of; 1) taking a blood sample from an individual; 2) adding LDS-751 and Thiazole-Orange to said sample; 3) adding a CD45 monoclonal antibody conjugated to phycoerythrin to said sample; 4) passing said sample through a flow cytometer having single laser source tuned to 488 nm and capable of recording and storing measurements of orthogonal and forward light scatter and of LDS-751, Thiazole-Orange and phycoerythrin fluorescence emissions for each cell in said sample.
Claim 17
Independent Claim
89 words
A method for five-parameter analysis of cells in a blood sample wherein said method comprises the steps of; 1) taking a blood sample from an individual; 2) adding LDS-751 and Thiazole-Orange to said sample; 3) adding a CD45 monoclonal antibody conjugated to phycoerythrin to said sample; 4) passing said sample through a flow cytometer having single laser source tuned to 488 nm and capable of recording and storing measurements of orthogonal and forward light scatter and of LDS-751, Thiazole-Orange and phycoerythrin fluorescence emissions for each cell in said sample.
Claim 18
Independent Claim
91 words
A method for five-parameter analysis of cells in a bone marrow sample wherein said method comprises the steps of: 1) taking a bone marrow sample from an individual; 2) adding LDS-751 and Thiazole-Orange to said sample; 3) adding a CD45 monoclonal antibody conjugated to phycoerythrin to said sample; 4) passing said sample through a flow cytometer having single laser source tuned to 488 nm and capable of recording and storing measurements of orthogonal and forward light scatter and of LDS-751, Thiazole-Orange and phycoerythrin fluorescence emissions for each cell in said sample.
Claim 19
Independent Claim
91 words
A method for five-parameter analysis of cells in a bone marrow sample wherein said method comprises the steps of: 1) taking a bone marrow sample from an individual; 2) adding LDS-751 and Thiazole-Orange to said sample; 3) adding a CD45 monoclonal antibody conjugated to phycoerythrin to said sample; 4) passing said sample through a flow cytometer having single laser source tuned to 488 nm and capable of recording and storing measurements of orthogonal and forward light scatter and of LDS-751, Thiazole-Orange and phycoerythrin fluorescence emissions for each cell in said sample.
References Cited (Backward Citations)
US3826364A
Cited
US3826364B1
Cited
US4284412A
Cited
US4544546A
Cited
US4520110A
Cited
US4661913A
Cited
US4727020A
Cited
US4883867A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-09 | 1995-03-11 | 1995-09-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-09 | 1999-03-11 | 1999-09-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-09 | 2003-03-11 | 2003-09-10 | $7700.00 | Window Closed / Lapsed |